chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Induration, Lymphadenopathy, Myalgia, Neck pain
Clinical narrative: Multiple, large, hard and soft swollen lymph nodes in neck and above and below clavicle in same arm as vaccine given; severe aches and pains in neck and upper back; severe aches and pains in neck and upper back; This is a spontaneous report from a contactable nurse (patient). A 59-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: EH9899; expiration date: unknown), via an unspecified route of administration right arm on 21Dec2020 12:00 PM at a single dose for covid-19 vaccination. Medical history included latex allergy. The patient's concomitant medications were not reported. The patient previously took telithromycin (KETEKS) and clonidine, but both had allergies. The patient received the most recent COVID-19 vaccine administered in a hospital. The patient reported that she had multiple large, hard and soft swollen lymph nodes in neck and above and below clavicle in same arm as vaccine given, severe aches and pains in neck and upper back on 27Dec2020. The patient did not received treatment for the adverse event. The events were considered as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 and has not been tested for COVID-19 since the vaccination. The adverse event resulted in a doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Lymphadenopathy, Neck pain
Clinical narrative: Multiple, large, hard and soft swollen lymph nodes in neck and above and below clavicle in same arm as vaccine given; severe aches and pains in neck and upper back; severe aches and pains in neck and upper back; This is a spontaneous report from a contactable nurse (patient). A 59-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: EH9899; expiration date: unknown), via an unspecified route of administration right arm on 21Dec2020 12:00 PM at a single dose for covid-19 vaccination. Medical history included latex allergy. The patient's concomitant medications were not reported. The patient previously took telithromycin (KETEKS) and clonidine, but both had allergies. The patient received the most recent COVID-19 vaccine administered in a hospital. The patient reported that she had multiple large, hard and soft swollen lymph nodes in neck and above and below clavicle in same arm as vaccine given, severe aches and pains in neck and upper back on 27Dec2020. The patient did not received treatment for the adverse event. The events were considered as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 and has not been tested for COVID-19 since the vaccination. The adverse event resulted in a doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: It is causing a decrease in mobility and effecting her mobility; soreness in her arm; This is a spontaneous report from a contactable nurse (patient). A 50-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection, lot number: EL1284) via an unspecified route of administration on the left arm on 23Dec2020 17:20 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the COVID vaccine and was still experiencing soreness in her arm for more than 2 weeks. She wanted to know if she should get the second dose. She also wanted to know if she does get the second dose can she ask for a different needle size and different injection site. She had soreness in her arm on 24Dec2020 and if it was related to the COVID Vaccine. The soreness in her arm is in the left arm where the site of injection was. She noticed when woke up like am in the morning. She had an X-Ray done yesterday 06Jan2021 and it did not show any type of dislocation or fracture. She stated she knew the soreness in the arm was most commonly seen 48 hours after getting the injection, the COVID shot, she knew this was a normal side effect. However, she was wondering why she is still experiencing this and it's going on 2.5 weeks now. She later clarified when speaking to previous agent they were providing the number to speak to someone more about the side effects and questions. She wanted to know why she was having it more than 2.5 weeks after getting it. She has read literature and she saw there where it can occur, but it indicated it would not be more than 72 hours. She was worried about this. It was causing a decrease in mobility and effecting her mobility. There was no history of all immunizations with the Pfizer Vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The events did not require a visit to the emergency room or physician office. Outcome of the event soreness in her arm was not recovered, while unknown for the other event.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Pain in extremity, X-ray
Clinical narrative: It is causing a decrease in mobility and effecting her mobility; soreness in her arm; This is a spontaneous report from a contactable nurse (patient). A 50-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection, lot number: EL1284) via an unspecified route of administration on the left arm on 23Dec2020 17:20 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the COVID vaccine and was still experiencing soreness in her arm for more than 2 weeks. She wanted to know if she should get the second dose. She also wanted to know if she does get the second dose can she ask for a different needle size and different injection site. She had soreness in her arm on 24Dec2020 and if it was related to the COVID Vaccine. The soreness in her arm is in the left arm where the site of injection was. She noticed when woke up like am in the morning. She had an X-Ray done yesterday 06Jan2021 and it did not show any type of dislocation or fracture. She stated she knew the soreness in the arm was most commonly seen 48 hours after getting the injection, the COVID shot, she knew this was a normal side effect. However, she was wondering why she is still experiencing this and it's going on 2.5 weeks now. She later clarified when speaking to previous agent they were providing the number to speak to someone more about the side effects and questions. She wanted to know why she was having it more than 2.5 weeks after getting it. She has read literature and she saw there where it can occur, but it indicated it would not be more than 72 hours. She was worried about this. It was causing a decrease in mobility and effecting her mobility. There was no history of all immunizations with the Pfizer Vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The events did not require a visit to the emergency room or physician office. Outcome of the event soreness in her arm was not recovered, while unknown for the other event.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Intensive care, Sinus tachycardia, Supraventricular tachycardia
Clinical narrative: tachycardia, hypertension, supraventricular tachycardia. Required adenosine x2, vagal maneuvers, IV bolus,  and Cardizem drip and over night observation
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood albumin normal, Blood calcium normal, Blood chloride normal
Clinical narrative: tachycardia, hypertension, supraventricular tachycardia. Required adenosine x2, vagal maneuvers, IV bolus,  and Cardizem drip and over night observation
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood creatinine normal, Blood glucose normal, Blood magnesium normal, Blood phosphorus decreased, Blood potassium decreased
Clinical narrative: tachycardia, hypertension, supraventricular tachycardia. Required adenosine x2, vagal maneuvers, IV bolus,  and Cardizem drip and over night observation
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood sodium normal, Blood urea normal, Carbon dioxide normal, Echocardiogram normal, Intensive care
Clinical narrative: tachycardia, hypertension, supraventricular tachycardia. Required adenosine x2, vagal maneuvers, IV bolus,  and Cardizem drip and over night observation
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Palpitations, Protein total normal, Sinus tachycardia, Supraventricular tachycardia
Clinical narrative: tachycardia, hypertension, supraventricular tachycardia. Required adenosine x2, vagal maneuvers, IV bolus,  and Cardizem drip and over night observation
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood thyroid stimulating hormone, Echocardiogram, Hypertension, Supraventricular tachycardia, Tachycardia
Clinical narrative: tachycardia, hypertension, supraventricular tachycardia. Required adenosine x2, vagal maneuvers, IV bolus,  and Cardizem drip and over night observation
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: vacc 12/30, pt states she broke out into generalized truncal rash which has now resolved, pt states it was severe, called PCP, was prescribed steroids, went to PCP, states burning and itching was awful, is hesitant to get booster
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Pruritus, Rash
Clinical narrative: vacc 12/30, pt states she broke out into generalized truncal rash which has now resolved, pt states it was severe, called PCP, was prescribed steroids, went to PCP, states burning and itching was awful, is hesitant to get booster
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Headache, Injection site erythema, Injection site swelling
Clinical narrative: Chest pains that have been on and off.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site warmth, Muscle twitching
Clinical narrative: Chest pains that have been on and off.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain
Clinical narrative: Chest pains that have been on and off.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Dizziness, Hyperhidrosis, Immediate post-injection reaction, Peripheral swelling
Clinical narrative: The patient received the first dose of Moderna Covid vaccine at their place of work on 12/22. They had no complaints after initial vaccination. On the morning of 12/23 the patient experienced light headedness, diaphoresis, tunnel vision, low blood pressure of unspecified and what could be described as a near-syncopal event. Patient states they did not lose consciousness or fall during this event. Patient then called EMS and was taken to ED by which time symptoms had mostly resolved. Still had complaints of general fatigue and arm pain. Patient received no medications and was supervised for 2-4 hours before being discharged. Of note patient previously had COVID in June and was hospitalized for 6 days, the patients pulmonary function remained stable during that admission.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: The patient received the first dose of Moderna Covid vaccine at their place of work on 12/22. They had no complaints after initial vaccination. On the morning of 12/23 the patient experienced light headedness, diaphoresis, tunnel vision, low blood pressure of unspecified and what could be described as a near-syncopal event. Patient states they did not lose consciousness or fall during this event. Patient then called EMS and was taken to ED by which time symptoms had mostly resolved. Still had complaints of general fatigue and arm pain. Patient received no medications and was supervised for 2-4 hours before being discharged. Of note patient previously had COVID in June and was hospitalized for 6 days, the patients pulmonary function remained stable during that admission.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Hyperhidrosis, Hypotension, Pain in extremity
Clinical narrative: The patient received the first dose of Moderna Covid vaccine at their place of work on 12/22. They had no complaints after initial vaccination. On the morning of 12/23 the patient experienced light headedness, diaphoresis, tunnel vision, low blood pressure of unspecified and what could be described as a near-syncopal event. Patient states they did not lose consciousness or fall during this event. Patient then called EMS and was taken to ED by which time symptoms had mostly resolved. Still had complaints of general fatigue and arm pain. Patient received no medications and was supervised for 2-4 hours before being discharged. Of note patient previously had COVID in June and was hospitalized for 6 days, the patients pulmonary function remained stable during that admission.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tunnel vision
Clinical narrative: The patient received the first dose of Moderna Covid vaccine at their place of work on 12/22. They had no complaints after initial vaccination. On the morning of 12/23 the patient experienced light headedness, diaphoresis, tunnel vision, low blood pressure of unspecified and what could be described as a near-syncopal event. Patient states they did not lose consciousness or fall during this event. Patient then called EMS and was taken to ED by which time symptoms had mostly resolved. Still had complaints of general fatigue and arm pain. Patient received no medications and was supervised for 2-4 hours before being discharged. Of note patient previously had COVID in June and was hospitalized for 6 days, the patients pulmonary function remained stable during that admission.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Blood test, Disturbance in attention, Dizziness, Electrocardiogram
Clinical narrative: Systemic: Patient experienced dizziness for about 2 hours, when trying to focus patient eyes were darting, blurred vision, and a little while later patient could not stand or walk alone
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging, Urine analysis
Clinical narrative: Systemic: Patient experienced dizziness for about 2 hours, when trying to focus patient eyes were darting, blurred vision, and a little while later patient could not stand or walk alone
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test normal, Computerised tomogram normal, Dizziness, Electrocardiogram normal, Gait disturbance
Clinical narrative: Systemic: Patient experienced dizziness for about 2 hours, when trying to focus patient eyes were darting, blurred vision, and a little while later patient could not stand or walk alone
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging normal, Urine analysis normal, Vertigo
Clinical narrative: Systemic: Patient experienced dizziness for about 2 hours, when trying to focus patient eyes were darting, blurred vision, and a little while later patient could not stand or walk alone
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dysstasia, Eye movement disorder, Gait inability, Vision blurred
Clinical narrative: Systemic: Patient experienced dizziness for about 2 hours, when trying to focus patient eyes were darting, blurred vision, and a little while later patient could not stand or walk alone
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Scattered hives on torso, bilateral arms/hands, neck and legs
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anosmia, Aphonia, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: tested positive/had the COVID infection/cough; tested positive/had the COVID infection/cough; PFIZER-BIONTECH COVID-19 VACCINE at 1.3 mL; This is a spontaneous report from a contactable nurse (patient). A 39-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 19Dec2020 at 1.3 mL, single for COVID-19 immunization. There were no medical history and concomitant medications. She received the first COVID-19 vaccine dose on 19Dec2020 then she tested positive on 22Dec2020. She got the first dose of the COVID vaccine and now she had the COVID infection. She was wondering if she should continue to get the second dose. She was also wondering if it will affect whether or not she gets the second dose. She couldn't find information online about what to do. Before she got the vaccine, she did take a test on an unspecified date to make sure she was negative, and she was. She had a cough at the end of the call. Outcome of the events was unknown.  Information on lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 and suspected LOE  due to temporal relationship.   There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: tested positive/had the COVID infection/cough; tested positive/had the COVID infection/cough; PFIZER-BIONTECH COVID-19 VACCINE at 1.3 mL; This is a spontaneous report from a contactable nurse (patient). A 39-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 19Dec2020 at 1.3 mL, single for COVID-19 immunization. There were no medical history and concomitant medications. She received the first COVID-19 vaccine dose on 19Dec2020 then she tested positive on 22Dec2020. She got the first dose of the COVID vaccine and now she had the COVID infection. She was wondering if she should continue to get the second dose. She was also wondering if it will affect whether or not she gets the second dose. She couldn't find information online about what to do. Before she got the vaccine, she did take a test on an unspecified date to make sure she was negative, and she was. She had a cough at the end of the call. Outcome of the events was unknown.  Information on lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 and suspected LOE  due to temporal relationship.   There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature increased, Dyspnoea
Clinical narrative: Systemic: Anaphylaxis, Systemic: Fever
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Pyrexia
Clinical narrative: Systemic: Anaphylaxis, Systemic: Fever
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea, Tachycardia
Clinical narrative: While driving home, I felt very tachycardic. I assessed pulse as being 165 and returned to the vaccination clinic. By the time I returned, felt dizzy and nauseated. Medical command was contacted who advised for paramedics on site to administer 50 mg of Benadryl IV as well as 4 mg of Zofran and an IV fluid bolus. Those treatments were executed, the tachycardia resolved and the  I felt better. I was transported to the Hospital for further evaluation and treatment as a precaution.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Rash over all over body, started at neck.; itching; This is a spontaneous report from a contactable Nurse. A 25-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3246, expiry date: unknown), intramuscular on 06Jan2021 15:15 at single dose (Left arm) for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Facility type vaccine was Clinic/Facility. The patient experienced rash over all over body, started at neck and also complained of itching on 06Jan2021 15:30. Patient denied breathing difficulties. EMTs arrived and gave client oxygen and Benadryl. AE resulted in Emergency room/department or urgent care. It was unknown if patient had COVID prior vaccination. The patient was not tested for COVID post vaccination. Therapeutic measures were taken as a result of rash over all over body, started at neck and itching. The outcome of the events was recovering.; Sender's Comments: Based on the close temporal association, the Company considers the events rash and pruritus are possibly related to vaccination with BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: arm red and sore approx 10 cm in diameter
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pain in extremity
Clinical narrative: arm red and sore approx 10 cm in diameter
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cellulitis, Fatigue, Injection site erythema, Injection site mass, Injection site pain
Clinical narrative: Hives and egg bump that formed around the shot area.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Injection site pruritus, Limb discomfort, Paraesthesia
Clinical narrative: Hives and egg bump that formed around the shot area.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Injection site cellulitis, Injection site hypoaesthesia, Injection site pain, Injection site paraesthesia
Clinical narrative: Hives and egg bump that formed around the shot area.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Injection site pruritus, Injection site reaction, Injection site swelling, Paraesthesia, Rash macular
Clinical narrative: Hives and egg bump that formed around the shot area.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Injection site swelling, Injection site urticaria
Clinical narrative: Hives and egg bump that formed around the shot area.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cellulitis, Fatigue, Hypersensitivity, Injection site erythema, Injection site mass
Clinical narrative: Hives and egg bump that formed around the shot area.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Injection site swelling, Injection site warmth, Limb discomfort, Paraesthesia
Clinical narrative: Hives and egg bump that formed around the shot area.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Fatigue, Hypoaesthesia, Injection site mass, Injection site pain
Clinical narrative: Hives and egg bump that formed around the shot area.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Injection site pruritus, Injection site warmth, Pain in extremity, Paraesthesia
Clinical narrative: Hives and egg bump that formed around the shot area.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: The patient developed swelling of left jawline and L side of lips that began 12-14 hours after injection. She denies any other symptoms. Denies itching or pain of area. Denies swelling of tongue or throat. Denies shortness of breath. Was seen by her PCP and symptoms were attributed to angioedema due to ACEi medication.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Decreased appetite, Headache, Nausea, Pain
Clinical narrative: On 12/28/2020 at 1930 I had a throbbing HA, nausea, chills, no appetite, body aches, extreme fatigue and low grade fever. Temp was 99.4-100.3. 1 gram of Tylenol was taken that evening, to relieve HA pain. Zofran 4 mg ODT was also taken for nausea. The following morning,  I felt extremely fatigued and had a persistent headache that was not consistently responsive to OTC meds. I developed a fever on 12/29/2020 in the evening. Low grade and ranging 99.3-100.6. Along with fever, my s/s were extreme fatigue, no appetite, headache, body aches, chills. On 12/30/2020, I spiked a Tmax of 101.0 around 11 am. Again, the same s/s were there. I went home from work early.  Same s/s and low grade fever persisted past 7 days, so I called my PCP as well as the Pharmacy where I received the vaccine. On the 10th day after vaccination, I notified my Infectious Disease Dr. He advised me to wait 6 months to 1 year to receive the second injection. He stated that my s/s were likely vaccine related and would go away with time. Fever persists through every day for the month of January 2021, with exact same symptoms. Started to notice Shortness of breath with activity, occasional sharp pain in chest. Presented to ER on 01/09/2021 with chest pain and shortness of breath. Labs revealed Acute Kidney Injury and Transaminitis. Cardiac work-up was performed, all tests negative. I was hypotensive. MD recommended I either get transferred to hospital, or stay in ER for min 23 hours observation for monitoring of kidney function and blood pressure. I received 2 L of Normal Saline. BP eventually began to rise with SBP above 90 and DBP above 40. (Normal BP range for me is 120/60-70's. Baseline Creatinine is 0.9. Discharged from ER per patient request, after second Creatinine level came down to 1.5. MD advised patient to not return to work for the next 2 business days. Spoke with PCP on 1/11/2021 in AM, and informed him of the events over the weekend. Also informed him that I am still febrile with same symptoms as reported previously. Was told I could not return to work until I was fever free. Was fever free for about 12 hours, until evening of 1/12/2021. MD not allow patient to RTW.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: On 12/28/2020 at 1930 I had a throbbing HA, nausea, chills, no appetite, body aches, extreme fatigue and low grade fever. Temp was 99.4-100.3. 1 gram of Tylenol was taken that evening, to relieve HA pain. Zofran 4 mg ODT was also taken for nausea. The following morning,  I felt extremely fatigued and had a persistent headache that was not consistently responsive to OTC meds. I developed a fever on 12/29/2020 in the evening. Low grade and ranging 99.3-100.6. Along with fever, my s/s were extreme fatigue, no appetite, headache, body aches, chills. On 12/30/2020, I spiked a Tmax of 101.0 around 11 am. Again, the same s/s were there. I went home from work early.  Same s/s and low grade fever persisted past 7 days, so I called my PCP as well as the Pharmacy where I received the vaccine. On the 10th day after vaccination, I notified my Infectious Disease Dr. He advised me to wait 6 months to 1 year to receive the second injection. He stated that my s/s were likely vaccine related and would go away with time. Fever persists through every day for the month of January 2021, with exact same symptoms. Started to notice Shortness of breath with activity, occasional sharp pain in chest. Presented to ER on 01/09/2021 with chest pain and shortness of breath. Labs revealed Acute Kidney Injury and Transaminitis. Cardiac work-up was performed, all tests negative. I was hypotensive. MD recommended I either get transferred to hospital, or stay in ER for min 23 hours observation for monitoring of kidney function and blood pressure. I received 2 L of Normal Saline. BP eventually began to rise with SBP above 90 and DBP above 40. (Normal BP range for me is 120/60-70's. Baseline Creatinine is 0.9. Discharged from ER per patient request, after second Creatinine level came down to 1.5. MD advised patient to not return to work for the next 2 business days. Spoke with PCP on 1/11/2021 in AM, and informed him of the events over the weekend. Also informed him that I am still febrile with same symptoms as reported previously. Was told I could not return to work until I was fever free. Was fever free for about 12 hours, until evening of 1/12/2021. MD not allow patient to RTW.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, C-reactive protein normal, Chest pain, Chills, Decreased appetite
Clinical narrative: On 12/28/2020 at 1930 I had a throbbing HA, nausea, chills, no appetite, body aches, extreme fatigue and low grade fever. Temp was 99.4-100.3. 1 gram of Tylenol was taken that evening, to relieve HA pain. Zofran 4 mg ODT was also taken for nausea. The following morning,  I felt extremely fatigued and had a persistent headache that was not consistently responsive to OTC meds. I developed a fever on 12/29/2020 in the evening. Low grade and ranging 99.3-100.6. Along with fever, my s/s were extreme fatigue, no appetite, headache, body aches, chills. On 12/30/2020, I spiked a Tmax of 101.0 around 11 am. Again, the same s/s were there. I went home from work early.  Same s/s and low grade fever persisted past 7 days, so I called my PCP as well as the Pharmacy where I received the vaccine. On the 10th day after vaccination, I notified my Infectious Disease Dr. He advised me to wait 6 months to 1 year to receive the second injection. He stated that my s/s were likely vaccine related and would go away with time. Fever persists through every day for the month of January 2021, with exact same symptoms. Started to notice Shortness of breath with activity, occasional sharp pain in chest. Presented to ER on 01/09/2021 with chest pain and shortness of breath. Labs revealed Acute Kidney Injury and Transaminitis. Cardiac work-up was performed, all tests negative. I was hypotensive. MD recommended I either get transferred to hospital, or stay in ER for min 23 hours observation for monitoring of kidney function and blood pressure. I received 2 L of Normal Saline. BP eventually began to rise with SBP above 90 and DBP above 40. (Normal BP range for me is 120/60-70's. Baseline Creatinine is 0.9. Discharged from ER per patient request, after second Creatinine level came down to 1.5. MD advised patient to not return to work for the next 2 business days. Spoke with PCP on 1/11/2021 in AM, and informed him of the events over the weekend. Also informed him that I am still febrile with same symptoms as reported previously. Was told I could not return to work until I was fever free. Was fever free for about 12 hours, until evening of 1/12/2021. MD not allow patient to RTW.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fatigue, Full blood count abnormal, Headache, Hypotension
Clinical narrative: On 12/28/2020 at 1930 I had a throbbing HA, nausea, chills, no appetite, body aches, extreme fatigue and low grade fever. Temp was 99.4-100.3. 1 gram of Tylenol was taken that evening, to relieve HA pain. Zofran 4 mg ODT was also taken for nausea. The following morning,  I felt extremely fatigued and had a persistent headache that was not consistently responsive to OTC meds. I developed a fever on 12/29/2020 in the evening. Low grade and ranging 99.3-100.6. Along with fever, my s/s were extreme fatigue, no appetite, headache, body aches, chills. On 12/30/2020, I spiked a Tmax of 101.0 around 11 am. Again, the same s/s were there. I went home from work early.  Same s/s and low grade fever persisted past 7 days, so I called my PCP as well as the Pharmacy where I received the vaccine. On the 10th day after vaccination, I notified my Infectious Disease Dr. He advised me to wait 6 months to 1 year to receive the second injection. He stated that my s/s were likely vaccine related and would go away with time. Fever persists through every day for the month of January 2021, with exact same symptoms. Started to notice Shortness of breath with activity, occasional sharp pain in chest. Presented to ER on 01/09/2021 with chest pain and shortness of breath. Labs revealed Acute Kidney Injury and Transaminitis. Cardiac work-up was performed, all tests negative. I was hypotensive. MD recommended I either get transferred to hospital, or stay in ER for min 23 hours observation for monitoring of kidney function and blood pressure. I received 2 L of Normal Saline. BP eventually began to rise with SBP above 90 and DBP above 40. (Normal BP range for me is 120/60-70's. Baseline Creatinine is 0.9. Discharged from ER per patient request, after second Creatinine level came down to 1.5. MD advised patient to not return to work for the next 2 business days. Spoke with PCP on 1/11/2021 in AM, and informed him of the events over the weekend. Also informed him that I am still febrile with same symptoms as reported previously. Was told I could not return to work until I was fever free. Was fever free for about 12 hours, until evening of 1/12/2021. MD not allow patient to RTW.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Liver function test increased, Nausea, Neutrophil count increased, Pain, Pyrexia
Clinical narrative: On 12/28/2020 at 1930 I had a throbbing HA, nausea, chills, no appetite, body aches, extreme fatigue and low grade fever. Temp was 99.4-100.3. 1 gram of Tylenol was taken that evening, to relieve HA pain. Zofran 4 mg ODT was also taken for nausea. The following morning,  I felt extremely fatigued and had a persistent headache that was not consistently responsive to OTC meds. I developed a fever on 12/29/2020 in the evening. Low grade and ranging 99.3-100.6. Along with fever, my s/s were extreme fatigue, no appetite, headache, body aches, chills. On 12/30/2020, I spiked a Tmax of 101.0 around 11 am. Again, the same s/s were there. I went home from work early.  Same s/s and low grade fever persisted past 7 days, so I called my PCP as well as the Pharmacy where I received the vaccine. On the 10th day after vaccination, I notified my Infectious Disease Dr. He advised me to wait 6 months to 1 year to receive the second injection. He stated that my s/s were likely vaccine related and would go away with time. Fever persists through every day for the month of January 2021, with exact same symptoms. Started to notice Shortness of breath with activity, occasional sharp pain in chest. Presented to ER on 01/09/2021 with chest pain and shortness of breath. Labs revealed Acute Kidney Injury and Transaminitis. Cardiac work-up was performed, all tests negative. I was hypotensive. MD recommended I either get transferred to hospital, or stay in ER for min 23 hours observation for monitoring of kidney function and blood pressure. I received 2 L of Normal Saline. BP eventually began to rise with SBP above 90 and DBP above 40. (Normal BP range for me is 120/60-70's. Baseline Creatinine is 0.9. Discharged from ER per patient request, after second Creatinine level came down to 1.5. MD advised patient to not return to work for the next 2 business days. Spoke with PCP on 1/11/2021 in AM, and informed him of the events over the weekend. Also informed him that I am still febrile with same symptoms as reported previously. Was told I could not return to work until I was fever free. Was fever free for about 12 hours, until evening of 1/12/2021. MD not allow patient to RTW.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Red blood cell count decreased, Red blood cell sedimentation rate normal, SARS-CoV-2 test negative, Transaminases increased, White blood cell count
Clinical narrative: On 12/28/2020 at 1930 I had a throbbing HA, nausea, chills, no appetite, body aches, extreme fatigue and low grade fever. Temp was 99.4-100.3. 1 gram of Tylenol was taken that evening, to relieve HA pain. Zofran 4 mg ODT was also taken for nausea. The following morning,  I felt extremely fatigued and had a persistent headache that was not consistently responsive to OTC meds. I developed a fever on 12/29/2020 in the evening. Low grade and ranging 99.3-100.6. Along with fever, my s/s were extreme fatigue, no appetite, headache, body aches, chills. On 12/30/2020, I spiked a Tmax of 101.0 around 11 am. Again, the same s/s were there. I went home from work early.  Same s/s and low grade fever persisted past 7 days, so I called my PCP as well as the Pharmacy where I received the vaccine. On the 10th day after vaccination, I notified my Infectious Disease Dr. He advised me to wait 6 months to 1 year to receive the second injection. He stated that my s/s were likely vaccine related and would go away with time. Fever persists through every day for the month of January 2021, with exact same symptoms. Started to notice Shortness of breath with activity, occasional sharp pain in chest. Presented to ER on 01/09/2021 with chest pain and shortness of breath. Labs revealed Acute Kidney Injury and Transaminitis. Cardiac work-up was performed, all tests negative. I was hypotensive. MD recommended I either get transferred to hospital, or stay in ER for min 23 hours observation for monitoring of kidney function and blood pressure. I received 2 L of Normal Saline. BP eventually began to rise with SBP above 90 and DBP above 40. (Normal BP range for me is 120/60-70's. Baseline Creatinine is 0.9. Discharged from ER per patient request, after second Creatinine level came down to 1.5. MD advised patient to not return to work for the next 2 business days. Spoke with PCP on 1/11/2021 in AM, and informed him of the events over the weekend. Also informed him that I am still febrile with same symptoms as reported previously. Was told I could not return to work until I was fever free. Was fever free for about 12 hours, until evening of 1/12/2021. MD not allow patient to RTW.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Arthralgia, Cardiovascular evaluation, Dizziness, Electrocardiogram
Clinical narrative: Day 1-3 Injection site pain; Muscle pain; Joint pain; Headaches; Dizziness; Nausea; Unable to raise my arm/arm weakness; Pain was at a 10 and I had to go to the ER for care; Fatigue/tiredness; This is a spontaneous report from a contactable other HCP (patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EK5730), on 30Dec2020 14:15 at single dose in Left arm for COVID-19 immunisation.  Facility where the most recent COVID-19 vaccine was administered was Hospital. Medical history included Breast cancer, Hypertension (HTN), high cholesterol, lymphedema, endometriosis, hysterectomy, myomectomies x 2, anxiety, seasonal allergies, hx of pleurisy x 3.  Known allergies included adhesive glue in tape and bandaids, pollen, dust, pet dander. The patient was not pregnant at the time of vaccination. Concomitant medication included escitalopram, losartan potassium 50 mg, anastrozole (ARIMIDEX). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Day 1-3 Injection site pain Day 6-7-muscle pain, joint pain, headaches, dizziness, nausea, unable to raise my arm/arm weakness, pain was at a 10 and  had to go to the ER for care, fatigue/tiredness. All the events were reported onset on 06Jan2021 18:00. AE resulted in Emergency room/department or urgent care. Received Morphine, Muscle relaxer, steroid via IV, RX as treatment. The events were assessed non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Injection site pain, Laboratory test abnormal, Mobility decreased
Clinical narrative: Day 1-3 Injection site pain; Muscle pain; Joint pain; Headaches; Dizziness; Nausea; Unable to raise my arm/arm weakness; Pain was at a 10 and I had to go to the ER for care; Fatigue/tiredness; This is a spontaneous report from a contactable other HCP (patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EK5730), on 30Dec2020 14:15 at single dose in Left arm for COVID-19 immunisation.  Facility where the most recent COVID-19 vaccine was administered was Hospital. Medical history included Breast cancer, Hypertension (HTN), high cholesterol, lymphedema, endometriosis, hysterectomy, myomectomies x 2, anxiety, seasonal allergies, hx of pleurisy x 3.  Known allergies included adhesive glue in tape and bandaids, pollen, dust, pet dander. The patient was not pregnant at the time of vaccination. Concomitant medication included escitalopram, losartan potassium 50 mg, anastrozole (ARIMIDEX). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Day 1-3 Injection site pain Day 6-7-muscle pain, joint pain, headaches, dizziness, nausea, unable to raise my arm/arm weakness, pain was at a 10 and  had to go to the ER for care, fatigue/tiredness. All the events were reported onset on 06Jan2021 18:00. AE resulted in Emergency room/department or urgent care. Received Morphine, Muscle relaxer, steroid via IV, RX as treatment. The events were assessed non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscular weakness, Myalgia, Nausea
Clinical narrative: Day 1-3 Injection site pain; Muscle pain; Joint pain; Headaches; Dizziness; Nausea; Unable to raise my arm/arm weakness; Pain was at a 10 and I had to go to the ER for care; Fatigue/tiredness; This is a spontaneous report from a contactable other HCP (patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EK5730), on 30Dec2020 14:15 at single dose in Left arm for COVID-19 immunisation.  Facility where the most recent COVID-19 vaccine was administered was Hospital. Medical history included Breast cancer, Hypertension (HTN), high cholesterol, lymphedema, endometriosis, hysterectomy, myomectomies x 2, anxiety, seasonal allergies, hx of pleurisy x 3.  Known allergies included adhesive glue in tape and bandaids, pollen, dust, pet dander. The patient was not pregnant at the time of vaccination. Concomitant medication included escitalopram, losartan potassium 50 mg, anastrozole (ARIMIDEX). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Day 1-3 Injection site pain Day 6-7-muscle pain, joint pain, headaches, dizziness, nausea, unable to raise my arm/arm weakness, pain was at a 10 and  had to go to the ER for care, fatigue/tiredness. All the events were reported onset on 06Jan2021 18:00. AE resulted in Emergency room/department or urgent care. Received Morphine, Muscle relaxer, steroid via IV, RX as treatment. The events were assessed non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Headache, Muscular weakness
Clinical narrative: Day 1-3 Injection site pain; Muscle pain; Joint pain; Headaches; Dizziness; Nausea; Unable to raise my arm/arm weakness; Pain was at a 10 and I had to go to the ER for care; Fatigue/tiredness; This is a spontaneous report from a contactable other HCP (patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EK5730), on 30Dec2020 14:15 at single dose in Left arm for COVID-19 immunisation.  Facility where the most recent COVID-19 vaccine was administered was Hospital. Medical history included Breast cancer, Hypertension (HTN), high cholesterol, lymphedema, endometriosis, hysterectomy, myomectomies x 2, anxiety, seasonal allergies, hx of pleurisy x 3.  Known allergies included adhesive glue in tape and bandaids, pollen, dust, pet dander. The patient was not pregnant at the time of vaccination. Concomitant medication included escitalopram, losartan potassium 50 mg, anastrozole (ARIMIDEX). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Day 1-3 Injection site pain Day 6-7-muscle pain, joint pain, headaches, dizziness, nausea, unable to raise my arm/arm weakness, pain was at a 10 and  had to go to the ER for care, fatigue/tiredness. All the events were reported onset on 06Jan2021 18:00. AE resulted in Emergency room/department or urgent care. Received Morphine, Muscle relaxer, steroid via IV, RX as treatment. The events were assessed non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Pain, Pain assessment, Vaccination site pain
Clinical narrative: Day 1-3 Injection site pain; Muscle pain; Joint pain; Headaches; Dizziness; Nausea; Unable to raise my arm/arm weakness; Pain was at a 10 and I had to go to the ER for care; Fatigue/tiredness; This is a spontaneous report from a contactable other HCP (patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EK5730), on 30Dec2020 14:15 at single dose in Left arm for COVID-19 immunisation.  Facility where the most recent COVID-19 vaccine was administered was Hospital. Medical history included Breast cancer, Hypertension (HTN), high cholesterol, lymphedema, endometriosis, hysterectomy, myomectomies x 2, anxiety, seasonal allergies, hx of pleurisy x 3.  Known allergies included adhesive glue in tape and bandaids, pollen, dust, pet dander. The patient was not pregnant at the time of vaccination. Concomitant medication included escitalopram, losartan potassium 50 mg, anastrozole (ARIMIDEX). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Day 1-3 Injection site pain Day 6-7-muscle pain, joint pain, headaches, dizziness, nausea, unable to raise my arm/arm weakness, pain was at a 10 and  had to go to the ER for care, fatigue/tiredness. All the events were reported onset on 06Jan2021 18:00. AE resulted in Emergency room/department or urgent care. Received Morphine, Muscle relaxer, steroid via IV, RX as treatment. The events were assessed non-serious.